A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B

Clinical trial NCT07200193 · RECRUITING

Trial details

NCT number: NCT07200193
Sponsor: nChroma Bio
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepaititis B

Start date: 2025-12-22
Primary completion: 2032-12-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.